格隆匯APP獲悉,根據聯交所最新權益披露資料顯示,2022年6月9日,藥明生物(02269.HK)獲The Capital Group Companies, Inc.在場內以每股均價70.82港元增持990.65萬股,涉資約7.02億港元。

  增持後,The Capital Group Companies, Inc.最新持股數目為302,577,937股,持股比例由6.94%上升至7.17%。

Post a comment

Your email address will not be published. Required fields are marked *